Determining obstructive or central sleep-disordered breathing requires accurate assessment of breathing movements. The QDC-Pro device uses the cRIP method to provide the best estimate of breathing movements from the thorax and abdominal walls.

The QDC-Pro also uses quantitative diagnostic calibration (QDC) to calibrate its RIP signals and is compact, lightweight and easy to use.


Features & Benefits

  • Within the SomnoStar™ sleep system, real-time tools are available during acquisition and scoring to aid in identifying apnea, hypopnea and RERA monitoring and identification
  • Assesses breathing disturbances more accurately when used in conjunction with the flow measurement (cannula, oro-nasal thermal airflow sensor, PAP mask)
  • Acts as the recommended alternative sensor for apnea and hypopnea detection when the primary sensor (cannula) fails
  • Easy patient hook up
  • Easy visual and numeric (% Vt change) comparison of each breath to the baseline breath
  • Using cRIP, technologists can more accurately titrate the patient’s therapy, helping to reduce over-titration and under-titration
  • Sleep medicine physicians can use the QDC-Pro for patients older than 2 years of age

Customer Education Resources

Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.

The Latest News From Vyaire

Vyaire Statement on imtmedical ag / Hamilton Patent Dispute

On June 17, 2020, the Swiss Supreme Court denied an appeal brought by imtmedical ag regarding a long-standing Swiss patent dispute concerning certain flow sensor types.

Read More
Vyaire Signs Framework Contract with European Commission for Delivery of Ventilators in Response to COVID-19 Pandemic

CHICAGO – May 14, 2020 – Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, announced today that Vyaire has been selected by the European Commission as a supplier of priority medical equipment to help address the COVID-19 pandemic.

Read More

Contact a Sales Representative